يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"non-bismuth quadruple therapy"', وقت الاستعلام: 1.21s تنقيح النتائج
  1. 1
    Non-Bismuth Quadruple Therapy, Sequential Therapy or High-Dose Esomeprazole and Amoxicillin Dual Therapy for First-Line Helicobacter pylori Eradication: A Prospective Randomized Study

    المؤلفون: Amine Elmekkaoui, Naima Abda, A Zazour, Z Ismaili, W Khannoussi, G Kharrasse, Meriem Zeriouh, Mouna Bouqfar

    المصدر: Cureus

    مصطلحات موضوعية: medicine.medical_specialty, Infectious Disease, 030204 cardiovascular system & hematology, dual high dose therapy, Gastroenterology, Esomeprazole, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, eradication, Medicine, Adverse effect, sequential therapy, Intention-to-treat analysis, biology, business.industry, non-bismuth quadruple therapy, General Engineering, Helicobacter pylori, Amoxicillin, biology.organism_classification, Regimen, Concomitant, helicobacter pylori, Public Health, business, 030217 neurology & neurosurgery, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b025e93621607746c50670b688e90679Test
    https://doi.org/10.7759/cureus.11837Test


    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Non-bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: A real-life study

    المؤلفون: Romano M., Gravina A. G., Nardone G., Federico A., Dallio M., Martorano M., Mucherino C., Romiti A., Avallone L., Granata L., Priadko K., Compare D., Tuccillo C., Romito M. R., Sgambato D., Miranda A., Romano L., Loguercio C., Bazzoli F., Zagari R. M.

    المساهمون: Romano, M., Gravina, A. G., Nardone, G., Federico, A., Dallio, M., Martorano, M., Mucherino, C., Romiti, A., Avallone, L., Granata, L., Priadko, K., Compare, D., Tuccillo, C., Romito, M. R., Sgambato, D., Miranda, A., Romano, L., Loguercio, C., Bazzoli, F., Zagari, R. M.

    مصطلحات موضوعية: antimicrobial resistance, Helicobacter pylori, non-bismuth quadruple therapy, Pylera

    العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000527665000001; volume:25; issue:4; firstpage:e12694; journal:HELICOBACTER; http://hdl.handle.net/11588/823808Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85083713667

    الإتاحة: https://doi.org/10.1111/hel.12694Test
    http://hdl.handle.net/11588/823808Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    Non-bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: A real-life study

    المؤلفون: C. Mucherino, Rocco Maurizio Zagari, Agnese Miranda, Luciana Avallone, Franco Bazzoli, Lorenzo Romano, A. Romiti, Carmelina Loguercio, Katerina Priadko, Debora Compare, Lucia Granata, Marco Martorano, Marco Romano, Antonietta Gerarda Gravina, Alessandro Federico, Concetta Tuccillo, Gerardo Nardone, Maria Raffaella Romito, D. Sgambato, Marcello Dallio

    المساهمون: Romano, M., Gravina, A. G., Nardone, G., Federico, A., Dallio, M., Martorano, M., Mucherino, C., Romiti, A., Avallone, L., Granata, L., Priadko, K., Compare, D., Tuccillo, C., Romito, M. R., Sgambato, D., Miranda, A., Romano, L., Loguercio, C., Bazzoli, F., Zagari, R. M., Romano M., Gravina A.G., Nardone G., Federico A., Dallio M., Martorano M., Mucherino C., Romiti A., Avallone L., Granata L., Priadko K., Compare D., Tuccillo C., Romito M.R., Sgambato D., Miranda A., Romano L., Loguercio C., Bazzoli F., Zagari R.M.

    المصدر: HelicobacterREFERENCES. 25(4)

    مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Gastroenterology, Drug Administration Schedule, Helicobacter Infections, Internal medicine, Clarithromycin, Clarithromycin resistance, Drug Resistance, Bacterial, Medicine, Humans, Helicobacter, antimicrobial resistance, Adverse effect, High prevalence, biology, Helicobacter pylori, business.industry, non-bismuth quadruple therapy, General Medicine, Middle Aged, biology.organism_classification, bacterial infections and mycoses, Pylera, Anti-Bacterial Agents, Regimen, Infectious Diseases, Treatment Outcome, Case-Control Studies, Patient Compliance, Drug Therapy, Combination, Female, Antacids, business, Life study, Bismuth, medicine.drug

    وصف الملف: STAMPA

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59b1588c5fe875eb3f34e2eac5f922c6Test
    https://pubmed.ncbi.nlm.nih.gov/32314519Test


    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy

    المؤلفون: Song, Zhiqiang, Zhou, Liya, Zhang, Jianzhong, He, Lihua, Bai, Peng, Xue, Yan

    المساهمون: Zhou, LY (reprint author), Peking Univ, Hosp 3, Dept Gastroenterol, Beijing 100871, Peoples R China., Peking Univ, Hosp 3, Dept Gastroenterol, Beijing 100871, Peoples R China., Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.

    المصدر: PubMed ; SCI

    مصطلحات موضوعية: Bismuth, Eradication, Helicobacter pylori, Levofloxacin, Non-bismuth quadruple therapy, Second-line, ANTIBIOTIC-RESISTANCE, STANDARD TRIPLE, RESCUE REGIMENS, INFECTION, METAANALYSIS, EFFICACY, TRIAL

    العلاقة: DIGESTIVE AND LIVER DISEASE.2016,48,(5),506-511.; 1390975; http://hdl.handle.net/20.500.11897/435067Test; WOS:000373721200008

    الإتاحة: https://doi.org/20.500.11897/435067Test
    https://doi.org/10.1016/j.dld.2016.01.002Test
    https://hdl.handle.net/20.500.11897/435067Test

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث